Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36265102

Cost Savings and Increased Access With Ultra-Low-Dose Immunotherapy.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2023 Jan 10
First author
Mitchell AP

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2023 Jan 10;41(2):222-232. doi: 10.1200/JCO.22.01015.
    note
    Source null
    related pmid
    36265101
    relationship
    Comment on

Authors and identifiers

  1. name
    Mitchell AP
    type
    Author
  2. name
    Goldstein DA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mitchell AP
    type
    Author
  2. name
    Goldstein DA
    type
    Author
bibliography ids
  1. nci-bib-8a160326dee91bf2bdc60984
book metadata
content sha256
7e33338334ff5a5437a1e03f9e22760f0fc7910468516d9715308b14e7ee58ae
document type
citation
dois
  1. 10.1200/JCO.22.01711
electronic publication date
display
2022 Oct 20
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:36265102
immutable id
pubmed:36265102@7e33338334ff5a5437a1e03f9e22760f0fc7910468516d9715308b14e7ee58ae
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
2
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
170-172
volume
41
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2023 Jan 10;41(2):222-232. doi: 10.1200/JCO.22.01015.
    note
    Source null
    related pmid
    36265101
    relationship
    Comment on
outcomes validated
false
pmid
36265102
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
97e5b121248f858b63913f39d744f19cf242c19b24ae8a03b36622159d91a245
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 Jan 10
precision
day
year
2023
publication types
  1. Editorial
  2. Comment
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36265102/
title
Cost Savings and Increased Access With Ultra-Low-Dose Immunotherapy.

Preserved source evidence · Not medical advice